Further, kidney transplant recipients with a high proportion CD57+ of CD8 T cells have elevated risk of squamous cell carcinoma (66), and kidney recipients with an elevated proportion of CD57+ TEMRA have an elevated risk of late graft dysfunction (67). Here, B3GAT1 is linked to squamous cell carcinoma.